Speaker: Vincent van Pesch, Adjunct Head of Neurology Department, Cliniques Universitaires Saint-Luc
What key insights will you be sharing in your session?
Vincent van Pesch: Hello. My presentation at ECTRIMS will focus on de-escalation or discontinuation strategies of high efficacy therapies in ageing MS patients. The management of high efficacy therapies in ageing MS poses unique challenges due to immunosenescence, increased prevalence of comorbidities and reduced physiological reserves, particularly the central nervous system. Moreover, changes in the pathophysiology of longstanding multiple sclerosis could also result in reduced treatment efficacy. Therefore, a careful re-evaluation of the risk-benefit balance of high efficacy therapies in ageing MS patients is needed. My presentation will review existing evidence, but also highlight current knowledge gaps concerning the management of high efficacy therapies in ageing MS patients.
Why is MSMilan2023 such an important event for MS experts and neurologists?
Vincent van Pesch: Attending the 2023 ECTRIMS congress in Milan is a great and exciting opportunity for neurologists and researchers worldwide to gather and exchange. This congress offers an immersive platform for attendees to engage and learn about cutting-edge research, innovative therapies and the latest technological advancements in the field. For all these reasons, attending ECTRIMS 2023 promises to be an enriching experience for all by sharing both clinical and scientific knowledge, establishing connections and ultimately advancing the understanding and treatment of multiple sclerosis and related disorders.
